Lin, E. https://orcid.org/0000-0002-1710-1866
Garmo, Hans
Van Hemelrijck, Mieke
Adolfsson, Jan
Stattin, Pär
Zethelius, Björn
Crawley, Danielle
Funding for this research was provided by:
Vetenskapsrådet (2017-00847)
The Swedish Cancer Society (16 0700)
The Stockholm Cancer Society (/)
Article History
Received: 18 November 2019
Accepted: 3 June 2020
First Online: 15 June 2020
Ethics approval and consent to participate
: The study has been approved by The Research Ethics Board at Uppsala University, Sweden.
: Not applicable.
: Hans Garmo, Mieke Van Hemelrijck, Jan Adolfsson, Pär Stattin and Björn Zethelius do not have competing interests. Björn Zethelius is employed at the Swedish Medical Products Agency, SE-751 03 Uppsala, Sweden. The views expressed in this paper are the personal views of the authors and not necessarily the views of the Swedish government agency.